What part of the word "imply" did you not understand?
Spin it any way you want but the fact is that the DMC gave Ridaforolimus the go ahead after the second interim results. Any thing else is complete conjecture on your part.
I agree with Biohedgee that Rida not getting the nod is not a posive. In my opinion his asking why it did not get the nod is rediculous. There are many possibilities and none of us are privy to the results. If you think Merck might have made a big mistake now might be a good time to sell if you are long the equity.